Kaiser Permanente Ventures

Portfolio Companies 2026 for Kaiser Permanente Ventures: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Kaiser Permanente Ventures accounts for 14 tracked companies with verified cap-table data, 14 of which disclose round sizes totalling $2.9B. The median disclosed raise is $160M, and the largest is Ursa Major at $506M, ahead of Ursa Major Technologies ($506M) and Gynesonics ($338M).

The names that recur most often on these portfolio cap tables are Kaiser Permanente Ventures (14 companies), Canaan Partners (3 companies), Lior Susan (2 companies), Gilman Louie (2 companies), Principia (2 companies), Woodline Partners (2 companies). By latest disclosed round, the market skews Series C (8), Series E (2), Series D (2), Series F (1).

Best funded Kaiser Permanente Ventures companies

  1. Ursa Major — $506M (latest: Series E)
  2. Ursa Major Technologies — $506M (latest: Series E)
  3. Gynesonics — $338M (latest: Series F)
  4. BIOAGE LABS — $300M (latest: Series D)
  5. Nimble Robotics — $221M (latest: Series C)
  6. Garner Health — $200M (latest: Series D)
  7. Vesta Healthcare — $160M (latest: Series C)
  8. Massachusetts General Hospital — $146M (latest: Series C)
  9. Kate Farms — $123M (latest: Series C)
  10. Ordr — $90M (latest: Series C)
  11. NOCD — $84M (latest: Series C)
  12. Iyiou Big Health — $75M (latest: Series C)
  13. Osso VR — $66M (latest: Series C)
  14. Genome Medical — $60M (latest: Series B)

Kaiser Permanente Ventures — related firms and companies (56)

Kaiser Permanente Ventures alternatives · All research reports